Signal transduction pathways: new targets for treating rheumatoid arthritis
Authors:
- Jacques MorelJMJacques Morel
- Francis BerenbaumFBFrancis Berenbaum
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Joint Bone Spine
- Vol. 71 (6) , 503-510
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Newer Immunosuppressive DrugsDrugs, 2002
- Signal transduction in rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2001
- NF-κB: a key role in inflammatory diseasesJournal of Clinical Investigation, 2001
- Tumor Necrosis Factor Receptor-Associated Factor (TRAF) Family: Adapter Proteins That Mediate Cytokine SignalingExperimental Cell Research, 2000
- p38 MAPK signalling cascades in inflammatory diseaseMolecular Medicine Today, 1999
- Transformation by v-Src: Ras-MAPK and PI3K-mTOR Mediate Parallel PathwaysMolecular Biology of the Cell, 1999
- Signal transduction and transcription factors in rheumatic diseaseArthritis & Rheumatism, 1999
- Signal transduction through NF-κBImmunology Today, 1998
- Activation of the MAP kinase homologue RK requires the phosphorylation of Thr‐180 and Tyr‐182 and both residues are phosphorylated in chemically stressed KB cellsFEBS Letters, 1995
- Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and ThreonineJournal of Biological Chemistry, 1995